|
1
|
Rubenstein J, Ferreri AJ and Pittaluga S:
Primary lymphoma of the central nervous system: epidemiology,
pathology and current approaches to diagnosis, prognosis and
treatment. Leuk Lymphoma. 49(Suppl 1): 43–51. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yoon JH, Kang HJ, Kim H, et al: Successful
treatment of primary central nervous system lymphoma without
irradiation in children: single center experience. J Korean Med
Sci. 27:1378–1384. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhagavathi S and Wilson JD: Primary
central nervous system lymphoma. Arch Pathol Lab Med.
132:1830–1834. 2008.PubMed/NCBI
|
|
4
|
Phillips EH, Fox CP and Cwynarski K:
Primary CNS lymphoma. Curr Hematol Malig Rep. 9:243–253. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haque S, Law M, Abrey LE and Young RJ:
Imaging of lymphoma of the central nervous system, spine, and
orbit. Radiol Clin North Am. 46:339–361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nayak L and Batchelor TT: Recent advances
in treatment of primary central nervous system lymphoma. Curr Treat
Options Oncol. 14:539–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perini GF, Campregher PV, Santos FP and
Hamerschlak N: Primary central nervous system lymphoma: what a
neurologist/neurosurgeon should know? Arq Neuropsiquiatr.
71:254–257. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brastianos PK and Batchelor TT: Primary
central nervous system lymphoma: overview of current treatment
strategies. Hematol Oncol Clin North Am. 26:897–916. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gallop-Evans E: Primary central nervous
system lymphoma. Clin Oncol (R Coll Radiol). 24:329–338. 2012.
View Article : Google Scholar
|
|
10
|
Olson JE, Janney CA, Rao RD, et al: The
continuing increase in the incidence of primary central nervous
system non-Hodgkin lymphoma: a surveillance, epidemiology, and end
results analysis. Cancer. 95:1504–1510. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kürtüncü M, Tüzün E, Durmuş H, Mutlu M,
Akman-Demir G and Eraksoy M: Primary cerebral lymphoma with a
5-year remission to single-agent corticosteroids. Leuk Lymphoma.
50:1552–1553. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jezersek Novakovic B: Treatment outcomes
and survival in patients with primary central nervous system
lymphomas treated between 1995 and 2010 - a single centre report.
Radiol Oncol. 46:346–353. 2012. View Article : Google Scholar
|
|
13
|
Bellinzona M, Roser F, Ostertag H, Gaab RM
and Saini M: Surgical and removal of primary central nervous system
lymphomas (PCNSL) presenting as space occupying lesions: a series
of 33 cases. Eur J Surg Oncol. 31:100–105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weller M, Martus P, Roth P, Thiel E and
Korfel A; German PCNSL Study Group. Surgery for primary CNS
lymphoma? Challenging a paradigm. Neuro Oncol. 14:1481–1484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ferreri AJ, Abrey LE, Blay JY, et al:
Summary statement on primary central nervous system lymphomas from
the Eighth International Conference on Malignant Lymphoma, Lugano,
Switzerland, June 12 to 15, 2002. J Clin Oncol. 21:2407–2414. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schorb E, Kasenda B, Atta J, et al:
Prognosis of patients with primary central nervous system lymphoma
after high-dose chemotherapy followed by autologous stem cell
transplantation. Haematologica. 98:765–770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pennese E, Vergine C, Matera R, Dargenio
M, Forese P and Di Renzo N: Complete response induced by
fotemustine given as single agent in a patient with primary central
nervous system non-Hodgkin aggressive lymphoma relapsed after
high-dose chemotherapy and autologous stem cell support. Leuk
Lymphoma. 52:2188–2189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiel E, Korfel A, Martus P, et al:
High-dose methotrexate with or without whole brain radiotherapy for
primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised,
non-inferiority trial. Lancet Oncol. 11:1036–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ferreri AJ, Verona C, Politi LS, Chiara A,
Perna L, Villa E and Reni M: Consolidation radiotherapy in primary
central nervous system lymphomas: impact on outcome of different
fields and doses in patients in complete remission after upfront
chemotherapy. Int J Radiat Oncol Biol Phys. 80:169–175. 2011.
View Article : Google Scholar
|
|
20
|
Correa DD, Shi W, Abrey LE, et al:
Cognitive functions in primary CNS lymphoma after single or
combined modality regimens. Neuro Oncol. 14:101–108. 2012.
View Article : Google Scholar :
|
|
21
|
Illerhaus G: Primary CNS lymphoma. Dtsch
Med Wochenschr. 138:2515–2518. 2013.(In German). PubMed/NCBI
|
|
22
|
Omuro A, Taillandier L, Chinot O, et al;
ANOCEF Group (French Neuro-Oncology Association). Primary CNS
lymphoma in patients younger than 60: can whole-brain radiotherapy
be deferred? J Neurooncol. 104:323–330. 2011. View Article : Google Scholar
|
